BioAtla, Inc. (BCAB)
NASDAQ: BCAB · Real-Time Price · USD
0.3300
-0.0291 (-8.10%)
At close: Aug 1, 2025, 4:00 PM
0.3366
+0.0066 (2.00%)
After-hours: Aug 1, 2025, 5:23 PM EDT
BioAtla Market Cap
BioAtla has a market cap or net worth of $19.28 million as of August 1, 2025. Its market cap has decreased by -80.46% in one year.
Market Cap
19.28M
Enterprise Value
-12.53M
1-Year Change
-80.46%
Ranking
Category
Stock Price
$0.33
Market Cap Chart
Since the IPO on December 16, 2020, BioAtla's market cap has decreased from $577.60M to $19.28M, a decrease of -96.66%. That is a compound annual growth rate of -52.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 20.98M | -38.85% |
| Dec 31, 2024 | 34.30M | -70.91% |
| Dec 29, 2023 | 117.92M | -69.81% |
| Dec 30, 2022 | 390.66M | -45.97% |
| Dec 31, 2021 | 723.09M | -36.84% |
| Dec 31, 2020 | 1.14B | 98.22% |
| Dec 16, 2020 | 577.60M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 682.35B |
| Johnson & Johnson | 402.82B |
| AbbVie | 334.40B |
| UnitedHealth Group | 241.34B |
| AstraZeneca | 236.88B |
| Novartis AG | 227.02B |
| Abbott Laboratories | 223.66B |
| Novo Nordisk | 221.96B |